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Heterogeneity of human serum amyloid A protein
Five different variants from one individual demonstrated by cDNA sequence analysis
Alexander STEINKASSERER, Elisabeth H. WEISS, Wilhelm SCHWAEBLE and Reinhold P. LINKE*
Institut fur Immunologie der Universitat Miinchen, Goethestrasse 31, D-8000 Munchen 2, Federal Republic of Germany
Serum amyloid A (SAA), a chemically polymorphic protein, is the most sensitive marker protein of the acute phase and
the precursor of reactive amyloidosis, which is characterized by deposits of amyloid A protein (AA). We investigated the
variability of the SAA gene family in one individual by sequencing 11 SAA-specific clones from an acute-phase-liver
cDNA library. At least five different SAA variants were deduced from six different cDNAs. The 3' untranslated gene
segments fall into two groups, based on nucleotide sequence and variability in length. Various nucleotide and amino acid
substitutions were found predominantly in the 3' portion. Some of these substitutions are unique and increase the number
of SAA variants in one individual to at least five. Moreover, genomic DNA of four individuals was examined by analysis
of restriction-fragment length polymorphism. Besides two conserved strongly labelled bands, additional polymorphic
bands were observed, indicating isotypic and/or allotypic SAA variations. Finally, three different mRNA species were
detected by Northern-blot analysis, a finding that might be of relevance for the stability of SAA transcripts.
INTRODUCTION
Amyloidosis secondary to chronic inflammations is caused by
systemic deposition of degradation-resistant fibrillar proteins.
These fibrils, which consist of amyloid A protein (AA), are
derived from serum amyloid A protein (SAA12) by limited
proteolysis (Benditt & Eriksen, 1977). Amyloid fibrils, including
the AA type, are diagnosed as amyloid in tissue sections on the
basis of their unique histochemical staining properties (Glenner,
1980a,b).
In plasma, SAA180 is a molecule of a1-protein electrophoretic
mobility (Levin et al., 1973) that is 180 kDa in size (Linke et al.,
1975) and has remarkable acute-phase properties (Gorevic et al.,
1976). After denaturation a 12 kDa molecule of fl-protein
electrophoretic mobility was identified and was designated
SAAL. Its physicochemical and immunochemical properties
differ from those of the native SAA180 molecule (Linke et al.,
1975; Linke, 1980). When SAAL was found to be associated
with high-density lipoprotein to form the 180 kDa complex, it
was also designated apoSAA (Benditt et al., 1982). SAA12, which
is composed of 104 amino acid residues and lacks cysteine as well
as carbohydrate (Parmelee et al., 1982), shows a microhetero-
geneity based on charge differences (Bausserman et al., 1980;
Marhaug & Husby, 1981; Skogen et al., 1986). This micro-
heterogeneity is also present in its derivative the 6-9 kDa AA
protein (Linke et al., 1975; Westermark, 1982).
These charge differences are assumed to be the result of
chemical differences and limited fragmentation. The total number
of human SAA genes and mRNAs is unclear. The amino acid
sequence data obtained from human AA-type amyloid fibrils
and the respective precursor proteins tend to indicate that there
are more than three genes.
Comparison of published data for SAA genomic and cDNA
clones points to the existence of at least three different SAA genes
in humans (Sipe et al., 1985; Sack & Lease, 1986; Kluve-
Beckerman et al., 1986, 1988; Woo et al., 1987). Four SAA genes
were found in the mouse, one being a pseudogene (Lowell et al.,
1986; Yamamoto et al., 1986, 1987). Interestingly, one SAA
isotype (SAA2) is the preferred amyloid-forming precursor in
mice (Meek & Benditt, 1986).
Our present study provides strong evidence for the existence of
more than three SAA genes in man: at least five different
mRNAs can be deduced from the seven cDNAs isolated from
one individual. Data on the variability at the genomic DNA level
indicative of SAA allotypes are also presented.
Part of this study was presented at the 9th European Im-
munology Meeting held in Rome (Steinkasserer et al., 1988).
MATERIALS AND METHODS
Identification of SAA cDNA clones
We isolated SAA-specific cDNA clones from a human acute-
phase-liver cDNA expression library (Stanley & Luzio, 1984).
This expression library, which was generously provided by K.
Stanley, was screened with a human SAA-specific cDNA (pAl;
Sipe et al., 1985; courtesy of Dr. J. D. Sipe) that had been
labelled with [32P]dATP (Amersham, Braunschweig, Germany)
by the polypriming method (Feinberg & Vogelstein, 1983). After
rescreening, positive clones were further characterized by
restriction-enzyme mapping and sequence analysis.
Sequence analysis of SAA cDNA
After purification of plasmid DNA, the cDNA inserts were
excised by PstI digestion and isolated by preparative agarose-gel
electrophoresis in accordance with standard protocol (Maniatis
et al., 1982). The PstI fragments were subcloned in the
bacteriophage vector M13 mpll (Boehringer, Mannheim,
Germany) and sequenced in both orientations by the dideoxy
chain-termination method described by Sanger et al. (1977).
Southern-blot analysis
We investigated the organization of SAA genes in the human
genome, using a 5' cDNA probe (pAS4) and a 3' cDNA probe
Abbreviations used: AA, amyloid A protein; SAA, serum amyloid A protein [the abbreviation SAA is used inconsistently in the literature to describe
the native 180 kDa or the denatured 12 kDa protein SAAL/apoSAA; we differentiate between SAA and SAAL/apoSAA by adding the molecular mass
as a subscript (SAA180, SAA12), when necessary].
* To whom correspondence should be addressed.
The nucleotide sequence data reported will appear in the EMBL, GenBank and DDBJ Nucleotide Sequence Databases under the accession numbers
X51439, X51440, X51441, X51442 and X51443 for the cDNA clones pASj, pAS2, pAS3., pAS3, and pAS4 respectively.
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Fig. 1. Overview of different SAA cDNA clones
Shown is the coding region of each PstI insert. Numbers above the pAS8 line refer to amino acid positions; arrows indicate the position of nucleic
acid variations as compared with clone pAl (Sipe et al., 1985). Full-length clone pAS8 is followed by two 5' clones (pAS6 and pAS4) and four 3'
clones (pASj, pAS2, pAS. and pAS3fl). Clone pAS6 is a truncated form of clone pAS8 and ends at amino acid 37.
(pAS1) for analysis of restriction-fragment length polymorphism.
Genomic DNA from four individuals was digested with four
restriction enzymes (TaqI, EcoRI, BglII and PstI; all from
Boehringer), and 10 jug of each digest was separated by
electrophoresis on a 0.7% agarose gel, transferred to Hybond-N
nylon membrane (Amersham), and hybridized with each cDNA
probe (1 x 106 c.p.m./ml) as described by Maniatis et al. (1982).
The oligonucleotides (oAS,, oAS2 and oAS8) were synthesized
(cyanoethyl method) by 'courtesy of R. Mertz (Genzentrum
Munich, Munich, Germany). Oligomer oAS2 is specific for the
translated region of clone pAS2, and oligomer oAS1 for the
short 3' untranslated region of clone pAS1 (for sequences see
Fig. 2). Hybridization conditions were established so that
each oligonucleotide specifically recognized only its identical
complementary sequence. Purification and hybridization of the
oligonucleotides were performed as described by Geliebter et al.
(1986). Oligomers were labelled with [32P]dATP (3000 Ci/mmol)
and terminal deoxynucleotidyltransferase (20 units/13 ,ul) to
high specific radioactivity as described by Collins & Hunsaker
(1985). Specific hybridization signals were obtained with labelled
oligomer (1 x 106 c.p.m./ml; hybridization temperatures were
for oAS1 64 °C, for oAS2 62 °C and for oAS8 55 °C) under the
stringent washing conditions described by Geliebter et al. (1986).
Analysis with oligonucleotides was performed on an EcoRI
digest of genomic DNA.
Northern-blot analysis
The 5' cDNA and 3' cDNA probes were also used to analyse
mRNA preparations from human acute-phase (non-neoplastic)
liver tissue from a patient with hepatoma and as control a biopsy
specimen from a patient with alcoholic hepatopathy without
detectable acute phase. RNA was fractionated by electrophoresis
on a 1.2% agarose gel and on a 6% polyacrylamide slab gel with
7 M-urea. Both were transferred to Hybond-N nylon membrane
by either capillary blotting or electrotransfer, and hybridized
with the radiolabelled SAA cDNA (pAS,) and oligonucleotide
probes oAS1, oAS2 and oAS8.
RESULTS
Isolation of SAA cDNA clones
Eleven cDNA clones were isolated by screening approx. 50000
colonies from an amplified liver cDNA library (Stanley & Luzio,
1984) with the SAA-specific cDNA probe pAl. The expression
cDNA library was prepared by subcloning cDNA PstI fragments
into the prokaryotic expression vector pEX2. Thus original
complete cDNA sequences with an internal PstI site cannot be
obtained as full-length clones but are obtained in two separate
plasmids. The SAA PstI inserts ranged from 300 bp to 700 bp.
Among the 11 cDNA clones four were completely identical,
yielding seven different inserts. Since clone pAS6 is a truncated
form of pAS8, six different DNA clones were found. pAS8 was
isolated as a full-length clone that lacks the internal PstI site. The
other isolated SAA sequences contained either the 5' half of the
SAA gene (pAS6 and pAS4) or the 3' end (pAS,, pAS2, pAS3U and
pAS3,6) (Fig. 2). Thus we have found five different 3' cDNA
segments, one in contiguity with the 5' end (pAS8) and four
(pASJ, pAS2, pAS3 and pAS3,) truncated as a consequence of
the internal PstI site. Since no information is available as to
which of the 5' segments is connected in the transcript with which
of the 3' segments, the minimal number of distinct transcripts
must be at least five.
Sequence comparison
All seven cDNA and the deduced polypeptide sequences are
listed in Fig. 2. They show various substitutions. Two cDNA
clones (pAS3., pAS3,f) are unique, and code for novel SAA
variants (see also Figs. 3 and 4). pAS3, is identical with the pAl
sequence (Sipe et al., 1985; renamed ApoSAAla by Woo et al.,
1987) with the exception of AAT (asparagine) instead of GAT
(aspartic acid) in position 60. This amino acid substitution is also
found in other SAA sequences [SAAg9 (Woo, 1986; Woo et al.,
1987) and pAS3, and pAS8 (the present psper)]. The sequence of
pAS3p differs from that of pAS3. at position 57, with alanine in
pAS3, and with valine in pAS3p, according to the designation
given by Parmelee et al. (1982).
Clone pAS1 represents the 3' segment (amino acid residues
54-104) and clone pAS4 represents the 5' part (amino acid
residues 1-54) of the pAl sequence. One silent nucleotide
substitution, however, is present at position 78 coding for alanine
(GCC instead of GCT). As all our 3' SAA cDNA clones contain
the GCC codon in this position, the difference therefore cannot
be explained as a cDNA cloning artifact. This nucleotide
exchange, which has also been described by Kluve-Beckerman
et al. (1986, 1988), may represent an allelic difference.
Clone pAS2 could be derived from the 3' segment of the
genomic clone SAAg9 (Woo et al., 1987), because it has an
identical nucleotide sequence.
Clone pAS8, lacking the internal PstI site, is identical with the
pSAA82 cDNA, renamed pSAA2a (Kluve-Beckerman et al.,
1986, 1988). In addition, a truncated 5' cDNA segment of pAS8
spanning 60 nucleotide residues from the 5' untranslated region
and the residues coding for the first 37 amino acid residues was
obtained and designated pAS6.
Some of the isolated cDNA clones differ only by one base
substitution. As the resulting amino acid exchanges have been
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Fig. 2. Nucleotide sequences of analysed SAA cDNA clones and deduced amino acid sequences
The different clones were isolated from one acute-phase liver. Clones pAl (Sipe et al., 1985) and pGS14/1 (Sack & Lease, 1986) are included for
comparison. All 3' clones extend into the poly(A) tail. Sequences for synthesis of the oligonucleotides oAS2, oAS1 and oAS8 are underlined. oAS8
(I) and oAS, (I9 almost cover the unique 64-89 segment and the 90-112 segment of the 3' untranslated region respectively. oAS2 (2) is derived
from a translated region of clone pAS2. A 25-nucleotide-residue deletion in the 3' untranslated region of clones pAS,, pAS, is designated by a
bar, and the polyadenylation recognition site by a broken line. The amino acid residues 52 and 57 specific for the a- and fl-forms of SAA
polypeptides are boxed.
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Fig. 3. Summary of SAA variants described at the protein level
SAA12 and AA-type amyloid fibril proteins are compared. The first
five sequences are from AA proteins and the last two are from
SAA12 proteins. Only the variant positions are listed. In some
instances two amino acids residues have been identified at the same
position, and both are stated.
found at the protein level (see Fig. 3), these variations are not due
to a cloning artifact and represent individual gene transcripts.
On the basis of the 3' untranslated region, our sequences fall
into two groups (see Table 1): group I (pAS1, pAS3. and pAS3,f)
has a 3' untranslated region that differs from the sequence of
group II (pAS2 and pAS8) by a deletion of 25 nucleotide residues
followed by a divergent segment of 23 nucleotide residues. This
segment in pAS1, pAS3. and pAS3. differs by nine bases from the
analogous sequence found in pAS2 and pAS8. Interestingly, this
dichotomy extends also to the coding region, in that group I
corresponds closely to the sequence of pAl. Members within
group II are virtually identical, but they differ from pAl at
positions 68, 69, 84 and 90. The amino acid exchanges between
pAl and pAS2/pAS8 include glutamic acid to lysine at position
84 and phenylalanine to threonine at position 69. The other three
exchanges are more conservative.
Two positions are found to be independent of the group I/II
pattern. In position 60 the exchange of aspartic acid in pAl to
asparagine is present in both groups. Another variable sub-
stitution concerns the a/fl variability (Parmelee et al., 1982) at
position 57. Whereas in group I both valine (/3-variant) in pAS3,f
and alanine (a-variant) in pAS1 and pAS3, were found, in group
II (pAS2 and pAS8) only the fl-variant was present.
Finally, in order to be able to distinguish nucleotide sequences
of group I from those of group II, oligonucleotide probes oAS1
and oAS8, specific for members of group I and II respectively,
were synthesized as indicated in Fig. 2.
Southern-blot analysis
To examine the variability of SAA on the genomic level, the
DNA of four individuals (K, LV, LR and JB) was digested with
endonuclease TaqI, EcoRI, BglII or PstI and tested with 5'
cDNA pAS4 and 3' cDNA pAS1. As shown in Figs. 5(a) and 5(b),
two strongly labelled bands and up to three weaker bands were
reproducibly detected in each digest with both probes. Additional
bands were observed in some individuals, indicating isotypic
and/or allotypic SAA variations.
Both cDNA probes hybridized strongly with 2.0 kb and 4.0 kb
TaqI fragments, whereas a 5.7 kb band was recognized less
intensely. However, a 5.9 kb TaqI fragment hybridized only with
the 5' cDNA clone (Fig. 5a). In addition, TaqI restriction
revealed polymorphic fragments in two unrelated individuals (K
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and LV). An additional 3.0 kb fragment was recognized by both
the 5' and the 3' SAA probes, and a 5.5 kb band was detected
with the 3' probe.
The EcoRI digest showed two strongly hybridizing bands
(1.5 kb and l1.0 kb) that were recognized by both plasmid
probes pAS, and pAS4. Since the two oligonucleotides bound to
different fragments, the 11.5 kb band detected with oAS2 (specific
for the translated region ofclone pAS2; Fig. 5d), may contain the
gene coding for pAS2, and the 11.0 kb band, which hybridized
with oAS1 (specific for the short 3' untranslated region of clones
pAS1, pAS3. and pAS38; Fig. Sc), could represent the genes
coding for pAS1, pAS3, and pAS3p (for sequence see Fig. 2). In
Table 1. Synopsis of cloned SAA sequences
Known SAA sequences are divided into three groups on the basis of
nucleotide sequence homology in the coding and the 3' untranslated
region. Concerning the a/,f variability see the text.
Clone a/fa Reference
Group I pAl (apoSAAla)
pAS1
pAS3a
pAS3p
Group II pSAA82 (pSAA2a)
SAAg9
pAS2
pAS8
Group III pGS14/1
a
a
aft
Sipe et al. (1985)
Present paper
Present paper
Present paper
ft Kluve-Beckerman et al.
(1986, 1988)
ft Woo et al. (1987)
ft Present paper
ft Present paper
ft Sack & Lease (1986)
addition, a 1.3 kb EcoRI band was only recognized with the 3'
cDNA probe pAS1 (Fig. Sb).
The BglII digest showed a 4.5 kb and a 12.5 kb band that were
recognized by both probes. Two additional fragments, a 0.7 kb
and a 6.0 kb band, only hybridized with the 3' probe (Fig. Sb).
The PstI restriction pattern is more complex, as might be
expected given the variant PstI restriction site in the cDNA
clones. The 3.0 kb PstI fragment may represent the gene coding
for pAS8 without the internal PstI site, because it was recognized
by both probes in all four individuals. A 1.4 kb and a 1.8 kb band
hybridized only with the 5' probe (Fig. Sa), whereas a 2.3 kb
fragment was detected with the 3' probe (Fig. Sb). A single
polymorphic 4.9 kb fragment recognized by both probes and
identified in only one individual (LV) is indicative of an allotypic
SAA variant.
Northern-blot analysis
The expression of SAA genes was investigated by Northern-
blot analysis, with separation of the mRNA by electrophoresis
on a 1.2% agarose gel. The hybridization signal in mRNA
isolated from acute-phase liver was always s?tiong and broad,
indicating a very large amount of SAA mRNA sent (see Fig.
6, lane a). We have previously shown that SAA transcripts can
only be detected in RNA isolated from acute-phase liver. No
mRNA was detectable in normal liver biopsies (Schwaeble et al.,
1987). Short exposure to X-ray film of the blot demonstrated the
presence of more than one mRNA species. Fractionation of the
RNA by electrophoresis on a polyacrylamide gel having a higher
resolution showed three distinct bands of approx. 530, 600 and
650 nucleotide residues (Fig. 6, lanes b-e).
With the 3' cDNA pAS1 as probe, the two larger mRNAs gave
roughly the same strong signal, whereas the 530-nucleotide
transcript hybridized more weakly (Fig. 6, lane b).
(b)
-. ..........-..._._...I......... .......
_I. _ _ _|- _ _ _-I _ ___ _ _K LV LRJB K LV LRJB K LVLRJB K LVLRJB
Taql EcoRI BgA Pstl Taql EcoRI Bg/lI
Fig. 5. Genomic Southern-blot analysis
Analysis of restriction-fragment length polymorphism of DNA isolated from four individuals (K, LV, LR and JB). DNA of each was digested
with four different restriction enzymes, separated by electrophoresis on a 0.7 0 agarose gel, transferred to nylon membrane and hybridized with
two probes: the 5' probe pAS4 (a) and the 3' probe pAS, (b). All relevant bands are labelled by a dash on the left-hand side. The 11.5 kb and
11.0 kb EcoRI fragments are denoted by arrows. Both fragments hybridize equally with plasmid probes but differentially with the oligomers. oAS2
recognized the 11.5 kb fragment (d) and oAS, the 11.0 kb band (c). For sequences of oligonucleotide probes see Fig. 2.
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Fig. 6. Northern-blot analysi's
RNA from a human acute-phase liver was separated by
electrophoresis on a 1.200 agarose gel (lane a) or on a
urea/polyacrylamide gel (lanes b-e), and hybridized with plasmid
probe pAS, (lanes a and b), oligomer oAS2 (lane c), oAS, (lane d)
and oAS, (lane e). For sequences of oligonucleotides see Fig. 2.
Abbreviation: nt, nucleotide residues.
Unexpectedly, the three oligonucleotides (oAS1, oAS2 and
oAS8) hybridized to each of the three mRNA bands, and no clear
difference could be found in their hybridization intensities. In
contrast with the hybridization signal obtained with the 3'
plasmid probe pAS1, the corresponding oligomer oAS1 and also
oAS2 and oAS8 gave the strongest signal with the 600-nucleotide
transcript. The large SAA mRNA species of 650 nucleotide
residues may therefore contain also other transcripts lacking the
3' untranslated sequences detected with our oligonucleotide
probes.
DISCUSSION
A minimum of five different transcripts can be deduced from
six different mRNAs identified from one organ. This is the largest
number of distinct SAA variants reported from one single
individual to date. The finding of multiple transcripts in the
acute-phase-liver cDNA library of one individual strongly
indicates that in man all these variants are translated during an
acute phase. This assumption corroborates data reported for the
mouse system by Meek & Benditt (1986) and Lowell et al. (1986).
In general, our cDNA sequences are more closely related to
the sequences encoded by pAl, SAAg9 and pSAA82 than to the
other type of variants represented by clone pGS14/1, which was
isolated with the use of a mouse clone pRS48 (Stearman et al.,
1982). The use of the pAl cDNA as screening probe may have
been responsible for the preferential isolation of more homo-
logous cDNA clones, since only strongly hybridizing colonies
were selected (see also discussion of the Southern-blot analysis
and Figs. Sa and Sb). The five clones presented covering the 3'
translated region fall into two distinct groups, based on identical
3' untranslated segments (group I, pAS1 and pAS., pAS3,8;
group II, pAS2 and pAS8; see Table 1). We assume these specific
3' segments to be related to a possible post-transcriptional
regulation of SAA gene expression. Since this group I/II vari-
ability extends to the coding region, two separate groups of genes
should be postulated.
One DNA segment (coding for amino acid residues 33-45) is
constant in all human SAA sequences, and no difference is found
at the protein level when compared with different species,
indicating an important function (Hermodsen et al., 1972;
Skinner et al., 1974; Gorevic et al., 1978; Waalen et al., 1980;
Parmelee et al., 1982; Sletten et al., 1983; Hoffman et al., 1984;
Lowell et al., 1986; Dwulet et al., 1988), and is consistent with
interspecies cross-reactivity (Linke et al., 1984).
On the basis of the degree of sequence homology, the known
human SAA sequences fall into three groups: group I and II
(mentioned above), and a third group represented by the clone
pGS14/1 (see Table 1). From sequence comparison we assume
the following evolutionary relation: after duplication of an
ancient gene, an ancestral pAl and an ancestral pGS14/1 gene
were formed. A more recent split of a pAI protogene resulted in
the two groups of pAl- and pSAA82-like genes. Comparison of
mouse SAA variants with the human analogues did not disclose
correspondence of any of the former to the latter. One therefore
can assume a parallel evolution of the mouse and the human
SAA genes, probably beginning at early Tertiary times. A similar
evolutionary tree of the mouse SAA gene family has been
proposed by Lowell et al. (1986).
The identification of a minimum of five distinct SAA transcripts
in one human acute-phase liver supports the assumption of a
multigene family coding for many SAA polypeptides. A minimal
number of three loci (isotypes) could explain the cDNA spectrum
in our study of a heterozygous individual; each locus then would
show considerable polymorphism.
Considering the variation of the SAA sequences, Southern-
blot analysis showed only few bands. Therefore SAA genes
appear to be similar, and the variations, mostly in the 3' half of
the genes, do not extend to the flanking region. The more weakly
hybridizing fragments (TaqI, 5.7 and 5.9 kb; EcoRI, 1.3 kb;
BglII, 6.0 kb band) might represent SAA genes that have less
sequence similarity to the probes used in our analysis. As bands
of similar size have been described by Sack et al. (1989) using a
probe derived from pGS14/1, we assume that the TaqI fragments
of 5.7 and 5.9 kb and the BglII band of 6.0 kb code for group III
homologous gene fragments. No weakly hybridizing fragments
are detected in the DNA digested with PstI. Thus with respect
to this restriction enzyme the divergent SAA sequences detected
with the probe used by Sack et al. (1989) and our probe are
similar with the exception of the 1.4 kb PstI band in Fig. 5(a).
Those authors also used a group-Il-derived genomic probe in
Southern-blot analysis but did not detect the 1.4 kb PstI band.
As their probe corresponding to our 5' probe contains mostly
intronic sequences, its use might have biased the hybridization
pattern to the detection of more homologous genes.
All polymorphic fragments revealed by Southern-blot analysis
in two individuals (TaqI, 3.0 and 5.5 kb; PstI, 4.9 kb band; Figs.
Sa and 5b; K and LV) are presumably derived from group-Ill-
like genes and are indicative of isotypes and allotypes. However,
only isolation of the entire region coding for SAA genes will
allow the exact identification of isotypic and allotypic sequences.
The results of Northern-blot analysis show that presumably all
members of the SAA multigene family are expressed during the
acute-phase induction. SAA transcripts were resolved into three
major mRNA species. The significance of the three SAA mRNA
species might be explained by differences in the length of the
poly(A) tail. Size alterations of the azl-acid glycoprotein mRNA
have already been shown in rat during the acute-phase reaction,
and these were due to a stepwise trimming of the poly(A) tail,
resulting in a few differently sized mRNA species (Shiels et al.,
1987). In addition, the length of the poly(A) tail is important for
the stability of mRNAs (Zeevi et al., 1982). Thus the 650-
nucleotide-residue transcript, with presumably the longest
poly(A) tail, might be the most stable SAA mRNA.
The finding that SAA12 polypeptides are coded by a gene
family and that presumably most of the SAA genes are turned on
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during acute-phase reactions underscore the necessity for con-
tinuing investigation on a possible differential function of these
molecules. In addition, like other members of multigene families,
e.g. the MHC antigens (Todd et al., 1988), it is conceivable that
some of the genes might be polymorphic, and specific amino acid
substitutions could result in additional amyloidogenic SAA12
precursor proteins (Gorevic et al., 1976).
Finally, the different cDNA clones presented in this study can
be used to characterize available monoclonal antibodies or to
generate variant-specific antibodies. These reagents may
recognize SAA variants that play an important role in the
pathogenesis of AA-type amyloidosis.
Note added in proof (received 2 April 1990)
After this paper was submitted, the complete sequence of the
human genomic SAA gene pGS 14/1 was reported by Sack &
Talbot (1989), which corresponds to the 'SAA-like' autocrine
collagenase inducer of the rabbit reported by Brinkerhoff et al.
(1989).
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